title: Nodular regenerative hyperplasia of the liver after IL-2 therapy in an HIV-infected patient.
authors.forename: Philippe
authors.initials: P
authors.lastname: Podevin
authors.forename: Gabriella
authors.initials: G
authors.lastname: Spiridon
authors.forename: Benoit
authors.initials: B
authors.lastname: Terris
authors.forename: Laurence
authors.initials: L
authors.lastname: Chauvelot-Moachon
authors.forename: Loic
authors.initials: L
authors.lastname: Guillevin
authors.forename: Stanislas
authors.initials: S
authors.lastname: Chaussade
authors.forename: Philippe
authors.initials: P
authors.lastname: Sogni
authors.forename: Dominique
authors.initials: D
authors.lastname: Salmon-Ceron
mesh_terms: D000368:Aged; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D007376:Interleukin-2 / Q000009:adverse effects*; D008099:Liver / Q000473:pathology*; D008297:Male
chemical_list: D007376:Interleukin-2